Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data across multiple studies demonstrating positive clinical and quality of life benefits of treatment with CFTR modulators and, in particular, ALYFTREK® (vanzacaftor/tezacaftor/deutivacaftor), which is approved in the United States and United Kingdom and is currently under review with health authorities in the EU, Canada, Australia, New Zealand and Switzerland. These data were presented at this year’s European Cystic Fibrosis S...
Kioxia Corporation, a world leader in memory solutions, today announced that it has received the IEEE Corporate Innovation Award from the Institute of Electrical & Electronics Engineers (IEEE), the world’s largest technical professional organization dedicated to advancing technology for the benefit of humanity. This award recognizes Kioxia's outstanding contribution in the field of electrical and electronics engineering through its BiCS FLASH™ technology, a low-cost, high-capacity 3D flash ...
VOOPOO is proud to introduce the groundbreaking iCOSM CODE 2.0 technology, a significant innovation that has garnered widespread acclaim within the vaping industry. This cutting-edge technology, featured in the ARGUS Top Fill Cartridge V2, seamlessly integrates Liquid-Seal Shield, Mega-Core, and Golden Cotton, offering a redefined vaping experience. VOOPOO warmly invites vaping enthusiasts to explore these advancements through the Test The Limits. This press release features multimedia. View th...
The TOURISE Awards officially launched today as a new global benchmark celebrating excellence in tourism destinations. Created to honor places that are shaping the future of travel, the Awards spotlight destinations delivering meaningful, memorable, and measurable value across the traveler journey. Nominations are now open to individual travelers, industry professionals, and organizations passionate about recognizing the world’s most exceptional places. This press release features multimedia. ...
Populous, the world-renowned design firm specializing in sport and entertainment venues, today announced the acquisition of Denver-based Fentress Architects, a global leader in iconic aviation projects and prominent public buildings, including convention centers, museums and government facilities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250606849000/en/Los Angeles International Airport. Designed by Fentress Architects. This s...
MSCI Inc. (NYSE:MSCI) and Moody’s Corporation (NYSE:MCO) will jointly create a first-of-its-kind solution to provide independent risk assessments for private credit investments at scale. As the private credit market continues to evolve and grow, the need for consistent standards and better tools has become essential for investors to assess, compare and communicate the risk of their investments. MSCI offers a unique and comprehensive universe of high-quality private capital data, sourced from ...
Perma-Pipe International Holdings, Inc. (Nasdaq: PPIH) today announced that it has received its first project award to be executed in Qatar since the announcement of the intent to mobilize there. The project will be for USD $2.4 million and will utilize Perma-Pipe’s fabrication capabilities and the XTRU-THERM® insulation system, a spray-applied polyurethane foam jacketed with a high-density polyethylene casing. Adham Sharkawy, Senior Vice President of Perma-Pipe’s MENA region, remarked, “In...
Aster DM Healthcare, one of the leading integrated healthcare providers in GCC & India, has announced the distinguished Grand Jury panel for the Aster Guardians Global Nursing Award 2025 to be held in Dubai on May 26, 2025. This esteemed panel includes five leading healthcare and nursing experts: Prof. Sheila Tlou, Co-Chairperson of the Global HIV Prevention Coalition, Botswana, Special Ambassador of the African Leaders Malaria Alliance and Former Minister of Health, Botswana; Prof. James B...
Novotech, a globally recognized full-service clinical research organization (CRO) and scientific advisory partner for biotech and small- to mid-sized pharmaceutical companies seeking to advance drug development, has released an in-depth report on the global clinical trial landscape for Idiopathic Pulmonary Fibrosis (IPF). The report offers strategic insights and comprehensive analysis critical for biotech and pharmaceutical companies navigating the complexities of IPF clinical research and drug...